Humana (NYSE:HUM) has recently introduced Humana Healthy Horizons, a new Medicaid plan for Virginians under Cardinal Care, highlighting its focus on expanding in the Medicaid sector. This move ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

This stock's P/B looks attractive against its industry's average P/B of 2.20. Within the past 52 weeks, HUM's P/B has been as high as 2.91 and as low as 1.52, with a median of 1.93.

Centene's 40% drop offers a buying opportunity as valuation becomes attractive. Read why I think CNC stock is now ...

Today, Zacks Equity Research discusses The Cigna Group CI, Humana Inc. HUM, Centene Corp. CNC and Molina Healthcare, Inc. MOH ...

Centene's stock plunged after slashing 2025 EPS guidance due to higher-than-expected morbidity and lower market growth in key ...

Detailed price information for Walt Disney Company (DIS-N) from The Globe and Mail including charting and trades.

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $243.33? Let's take a closer look at the ...

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

Shares of Humana Inc. (NYSE:HUM – Get Free Report) have received an average recommendation of “Hold” from the twenty-three ratings firms that are currently covering the firm, MarketBeat reports.